The evolution of treatment resistance: Biologic implications

Journal of Clinical Psychopharmacology

Volumn 18, Issue 2 SUPPL. 1, 1998, Pages

  Meltzer, Herbert Y ^a,b   Lee, Myung ^a   Cola, Philip ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Psychiatric Hospital at Vanderbilt   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HALOPERIDOL;

AFFECTIVE NEUROSIS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0031945606     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199804001-00003     Document Type: Conference Paper

References (22)

1. Lieberman J, Jody D, Geisler S, Alvir J, Loebel A. Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 1993;50:369-76.
2. Davis JM, Casper R. Antipsychotic drugs: clinical pharmacology and therapeutic use. Drugs 1977;14:260-82.
3. Kenny JT, Meltzer HY. Attention and higher cortical functions in schizophrenia. J Neuropsychiatry Clin Neurosci 1991;3: 269-75.
4. Bilder RM, Lipschutz-Broch L, Reiter G, Geisler SH, Mayerhoff DI, Lieberman JA. Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophr Bull 1992;18: 437-48.
5. Meltzer HY, Thompson PA, Lee MA, Ranjan R. Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment. Neuropsychopharmacology 1996; 14[suppl 3]:27S-33S.
6. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-96.
7. Hagger C, Buckley P, Kenny JT, Friedman L, Ubogy D, Meltzer HY. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiatry 1993;34:702-12.
8. Lee MA, Thompson PA, Meltzer HY. Effects of clozapine on cognitive function in schizophrenia. J Clin Psychiatry 1994;55[suppl B]:82-7.
9. Meltzer HY, Burnett S, Bastani B, Ramirez LF. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Community Psychiatry 1990;41: 892-7.
10. Manschreck TC, Redmond DA, Beaudette SM. Clozapine in the back wards. Ann Clin Psychiatry 1994;6:215-25.
11. Lindstrom LH. The effect of long-term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years. Acta Psychiatr Scand 1988; 77:524-9.
12. Meltzer HY. Dimensions of outcome with clozapine. Br J Psychiatry 1992;160[suppl 17]:46-53.
13. Meltzer HY, Okayli G. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am J Psychiatry 1995;152:183-90.
14. Meltzer HY, Fatemi H. Suicide in schizophrenia: the effect of clozapine. Clin Neuropharmacol 1995;18[suppl 3]:18S-24S.
15. Gerlach J, Koppelhus P, Helweg E, Monrad A. Clozapine and haloperidol in a single-blind cross-over trial: therapeutic and biochemical aspects in the treatment of schizophrenia. Acta Psychiatr Scand 1974;50:410-24.
16. Parsa MA, Al-Lanhram Y, Ramirez LF, Meltzer HY. Prolonged psychotic relapses after abrupt clozapine withdrawal. J Clin Psychopharmacol 1993:13:154-5.
17. Simpson GM, Lee JH, Shrivastava RK. Clozapine in tardive dyskinesia. Psychopharmacology (Berl) 1978;56:75-80.
18. Alphs LD, Lee HS. Comparison of withdrawal of typical and atypical antipsychotic drugs: a case study. J Clin Psychiatry 1991;52: 346-8.
19. Perenyi A, Kuncz E, Bagdy G. Early relapse after sudden withdrawal or dose reduction of clozapine. Psychopharmacology (Berl) 1985;86:244.
20. Meltzer HY, Lee MA, Ranjan R, Mason ED, Cola PA. Relapse following clozapine withdrawal: effect of cyproheptadine plus neuroleptic. Psychopharmacology (Berl) 1996;124: 176-87.
21. Meltzer HY. Treatment of the neuroleptic-nonresponsive schizophrenic patient. Schizophr Bull 1992;18:515-42.
22. Meltzer HY, Hippius H. The assessment and management of treatment-resistant schizophrenia in perspective. Eur Psychiatry 1995; 10[suppl 1]:S3-S5.